Mohamed, F.F.; Anhlan, D.; Schöfbänker, M.; Schreiber, A.; Classen, N.; Hensel, A.; Hempel, G.; Scholz, W.; Kühn, J.; Hrincius, E.R.;
et al. Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2. Pharmaceuticals 2022, 15, 530.
https://doi.org/10.3390/ph15050530
AMA Style
Mohamed FF, Anhlan D, Schöfbänker M, Schreiber A, Classen N, Hensel A, Hempel G, Scholz W, Kühn J, Hrincius ER,
et al. Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2. Pharmaceuticals. 2022; 15(5):530.
https://doi.org/10.3390/ph15050530
Chicago/Turabian Style
Mohamed, Fakry F., Darisuren Anhlan, Michael Schöfbänker, André Schreiber, Nica Classen, Andreas Hensel, Georg Hempel, Wolfgang Scholz, Joachim Kühn, Eike R. Hrincius,
and et al. 2022. "Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2" Pharmaceuticals 15, no. 5: 530.
https://doi.org/10.3390/ph15050530
APA Style
Mohamed, F. F., Anhlan, D., Schöfbänker, M., Schreiber, A., Classen, N., Hensel, A., Hempel, G., Scholz, W., Kühn, J., Hrincius, E. R., & Ludwig, S.
(2022). Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2. Pharmaceuticals, 15(5), 530.
https://doi.org/10.3390/ph15050530